vs

Side-by-side financial comparison of BeOne Medicines Ltd. (ONC) and QVC INC (QVCD). Click either name above to swap in a different company.

QVC INC is the larger business by last-quarter revenue ($2.4B vs $1.5B, roughly 1.6× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 1.5%, a 2.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -8.9%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 7.1%).

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

QVC Group, is an American media conglomerate controlled by company chairman John C. Malone, who owns a majority of the voting shares.

ONC vs QVCD — Head-to-Head

Bigger by revenue
QVCD
QVCD
1.6× larger
QVCD
$2.4B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+41.8% gap
ONC
32.8%
-8.9%
QVCD
Higher net margin
ONC
ONC
2.9% more per $
ONC
4.4%
1.5%
QVCD
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
7.1%
QVCD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ONC
ONC
QVCD
QVCD
Revenue
$1.5B
$2.4B
Net Profit
$66.5M
$37.0M
Gross Margin
90.5%
32.5%
Operating Margin
12.4%
5.6%
Net Margin
4.4%
1.5%
Revenue YoY
32.8%
-8.9%
Net Profit YoY
143.8%
103.0%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ONC
ONC
QVCD
QVCD
Q4 25
$1.5B
$2.4B
Q3 25
$1.4B
$2.0B
Q2 25
$1.3B
$2.0B
Q1 25
$1.1B
$1.9B
Q4 24
$1.1B
$2.7B
Q3 24
$1.0B
$2.1B
Q2 24
$929.2M
$2.1B
Q1 24
$751.7M
$2.1B
Net Profit
ONC
ONC
QVCD
QVCD
Q4 25
$66.5M
$37.0M
Q3 25
$124.8M
$2.0M
Q2 25
$94.3M
$-2.2B
Q1 25
$1.3M
$-42.0M
Q4 24
$-151.9M
$-1.2B
Q3 24
$-121.3M
$51.0M
Q2 24
$-120.4M
$53.0M
Q1 24
$-251.2M
$51.0M
Gross Margin
ONC
ONC
QVCD
QVCD
Q4 25
90.5%
32.5%
Q3 25
86.1%
33.6%
Q2 25
87.5%
35.4%
Q1 25
85.2%
33.3%
Q4 24
85.8%
32.6%
Q3 24
83.0%
34.7%
Q2 24
85.1%
35.6%
Q1 24
83.4%
35.0%
Operating Margin
ONC
ONC
QVCD
QVCD
Q4 25
12.4%
5.6%
Q3 25
11.5%
4.6%
Q2 25
6.7%
-114.5%
Q1 25
1.0%
1.5%
Q4 24
-7.0%
-47.1%
Q3 24
-12.0%
7.8%
Q2 24
-11.5%
7.6%
Q1 24
-34.8%
7.4%
Net Margin
ONC
ONC
QVCD
QVCD
Q4 25
4.4%
1.5%
Q3 25
8.8%
0.1%
Q2 25
7.2%
-109.1%
Q1 25
0.1%
-2.2%
Q4 24
-13.5%
-46.0%
Q3 24
-12.1%
2.4%
Q2 24
-13.0%
2.5%
Q1 24
-33.4%
2.4%
EPS (diluted)
ONC
ONC
QVCD
QVCD
Q4 25
$0.05
Q3 25
$0.08
Q2 25
$0.06
Q1 25
$0.00
Q4 24
$-0.10
Q3 24
$-0.09
Q2 24
$-0.09
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ONC
ONC
QVCD
QVCD
Cash + ST InvestmentsLiquidity on hand
$4.5B
$1.5B
Total DebtLower is stronger
$836.4M
$1.0M
Stockholders' EquityBook value
$4.4B
$1.2B
Total Assets
$8.2B
$8.5B
Debt / EquityLower = less leverage
0.19×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ONC
ONC
QVCD
QVCD
Q4 25
$4.5B
$1.5B
Q3 25
$4.0B
Q2 25
$2.8B
Q1 25
$2.5B
Q4 24
$2.6B
$297.0M
Q3 24
$2.7B
$297.0M
Q2 24
$2.6B
$315.0M
Q1 24
$2.8B
$311.0M
Total Debt
ONC
ONC
QVCD
QVCD
Q4 25
$836.4M
$1.0M
Q3 25
$5.0B
Q2 25
$4.0B
Q1 25
$4.0B
Q4 24
$3.3B
Q3 24
$3.4B
Q2 24
$3.7B
Q1 24
$3.8B
Stockholders' Equity
ONC
ONC
QVCD
QVCD
Q4 25
$4.4B
$1.2B
Q3 25
$4.1B
$1.2B
Q2 25
$3.8B
$1.2B
Q1 25
$3.5B
$3.3B
Q4 24
$3.3B
$3.3B
Q3 24
$3.4B
$4.6B
Q2 24
$3.4B
$4.3B
Q1 24
$3.4B
$4.2B
Total Assets
ONC
ONC
QVCD
QVCD
Q4 25
$8.2B
$8.5B
Q3 25
$7.6B
$8.3B
Q2 25
$6.3B
$7.4B
Q1 25
$5.8B
$9.7B
Q4 24
$5.9B
$9.9B
Q3 24
$5.8B
$9.9B
Q2 24
$5.7B
$11.2B
Q1 24
$5.7B
$11.4B
Debt / Equity
ONC
ONC
QVCD
QVCD
Q4 25
0.19×
0.00×
Q3 25
4.30×
Q2 25
3.42×
Q1 25
1.22×
Q4 24
1.01×
Q3 24
0.73×
Q2 24
0.87×
Q1 24
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ONC
ONC
QVCD
QVCD
Operating Cash FlowLast quarter
$417.3M
$245.0M
Free Cash FlowOCF − Capex
$379.8M
FCF MarginFCF / Revenue
25.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
6.28×
6.62×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ONC
ONC
QVCD
QVCD
Q4 25
$417.3M
$245.0M
Q3 25
$402.6M
$76.0M
Q2 25
$263.6M
$52.0M
Q1 25
$44.1M
$46.0M
Q4 24
$75.2M
$189.0M
Q3 24
$188.4M
$98.0M
Q2 24
$-95.6M
$164.0M
Q1 24
$-308.6M
$84.0M
Free Cash Flow
ONC
ONC
QVCD
QVCD
Q4 25
$379.8M
Q3 25
$354.5M
Q2 25
$219.8M
Q1 25
$-12.3M
Q4 24
$-17.3M
Q3 24
$54.7M
Q2 24
$-205.5M
Q1 24
$-465.1M
FCF Margin
ONC
ONC
QVCD
QVCD
Q4 25
25.4%
Q3 25
25.1%
Q2 25
16.7%
Q1 25
-1.1%
Q4 24
-1.5%
Q3 24
5.5%
Q2 24
-22.1%
Q1 24
-61.9%
Capex Intensity
ONC
ONC
QVCD
QVCD
Q4 25
2.5%
Q3 25
3.4%
Q2 25
3.3%
Q1 25
5.0%
Q4 24
8.2%
Q3 24
13.3%
Q2 24
11.8%
Q1 24
20.8%
Cash Conversion
ONC
ONC
QVCD
QVCD
Q4 25
6.28×
6.62×
Q3 25
3.22×
38.00×
Q2 25
2.79×
Q1 25
34.71×
Q4 24
Q3 24
1.92×
Q2 24
3.09×
Q1 24
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ONC
ONC

Segment breakdown not available.

QVCD
QVCD

Home$754.0M31%
QVC International$661.0M27%
Beauty$260.0M11%
Apparel$254.0M10%
Electronics$187.0M8%
Accessories$181.0M7%
Jewelry$87.0M4%
Otherrevenue$38.0M2%

Related Comparisons